VEGFA-targeting Gene Therapy to Treat Retinal and Choroidal Neovascularization Diseases

Clinical trial NCT05099094 · UNKNOWN

Trial details

NCT number: NCT05099094
Sponsor: Shanghai BDgene Co., Ltd.
Status: UNKNOWN
Phase: Early Phase 1
Study type: INTERVENTIONAL

Neovascular Age-related Macular Degeneration Diabetic Macular Edema Retinal Vein Occlusion

Start date: 2021-11-25
Primary completion: 2024-11-30
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.